![]() Financial Daily from THE HINDU group of publications Saturday, Jul 06, 2002 |
|
|
|
|
|
Corporate
-
New Projects Aurobindo sets up unit for generic anti-retrovirals Our Bureau
HYDERABAD, July 5 AUROBINDO Pharma Ltd (APL), the Hyderabad-based pharma major, has floated a separate division called `Institution', dedicated to offering anti-retrovirals in generic forms. In a press release, the Vice-President of APL, Mr Rony Batabyal, said offering anti-retrovirals in generic form would be much more economical to HIV-positive consumers. The new division would offer products in the three groups in the antiretroviral segment. According to Mr Batabyal, the cost of triple-drug therapy two years back was more than Rs 10,000 per month. "When Aurobindo launched its branded products in this segment, the same combinations cost around Rs 3,500 per month. Now, with the help of generic molecules, the company is confidant to offer at the cost at which all the needy will be able to afford the same." Stating that the company was already exporting the bulk and formulations of anti-retrovirals to different countries including South Africa, he said the company would be able to offer wider product options at affordable prices for the benefit of patients with the backing of global standard R&D and manufacturing facilities.
Send this article to Friends by E-Mail
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | Home |
Copyright © 2002, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|